BioSpace News Archive

Genetown

Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio

Sosei Group Corporation announces it has entered into a global collaboration and license agreement with Biohaven Pharmaceutical Holding Company Ltd..

December 1, 2020
·
8 min read
Policy

TearClear Announces Successful Completion of Pre-IND Meeting with the FDA for a Preservative Free Multi-Dose Delivery of Latanoprost for the Treatment of GlaucomaPrepared to file an IND in mid-2021 via the 505(b)(2) NDA pathway

TearClear, an emerging ophthalmic pharmaceutical company, announced successful completion of pre-IND meeting with the U.S. Food and Drug Administration regarding the development plan for the preservative free multi-dose delivery of a proprietary Latanoprost formulation, including the clinical study design for the registration study.

December 1, 2020
·
2 min read
Drug Development

Axsome Therapeutics Announces Positive Efficacy and Safety Results from Phase 3 COMET Long-Term Trial and COMET-AU Trial of AXS-05 in Major Depressive Disorder

Rapidand substantial improvement in depressive symptoms achieved by 40% of patients at 2 weeks, 73% at 6 weeks (MADRS response), and sustained over 12 months

December 1, 2020
·
18 min read
BioForest

NanoString Unveils Spatial Molecular Imaging Platform, Complementing GeoMx DSP to Provide Compelling Product Roadmap for Spatial Biology

Molecular Imaging Platform Leverages Hyb & Seq Chemistry to Spatially Profile Expression of 1,000+ Genes at Single Cell and Sub-Cell Resolution Across Tissue Samples

December 1, 2020
·
5 min read
Pharm Country

AdaptHealth Corp. Announces Acquisition of National HME Provider AeroCare Holdings Inc. and Updates Financial Guidance For 2021

Expected to significantly enhance scale and geographic reach, providing access to new customers and strengthening relationships with referral partners, patients, manufacturers, and managed healthcare plans

December 1, 2020
·
14 min read
Business

Caris Life Sciences Announces Vall d´Hebron Institute of Oncology Joins its Precision Oncology Alliance

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Spain’s Vall d´Hebron Institute of Oncology (VHIO) has joined Caris’ Precision Oncology Alliance™ (The Alliance/POA)

December 1, 2020
·
5 min read
Deals

Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business

Boston Scientific Corporation announced that it has entered into a definitive agreement with Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, to sell its BTG Specialty Pharmaceuticals business for $800 million in cash.

December 1, 2020
·
4 min read
Drug Development

Junshi Biosciences Announces Dosing of First Patient in Phase I Study of Anti-TROP2 Antibody -TUB196 Conjugate

Junshi Biosciences, an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, is pleased to announce that the Phase I clinical study of a recombinant humanized anti-TROP2 monoclonal antibody - Tub196 conjugate, has completed the dosing of the first patient.

December 1, 2020
·
3 min read
PACS and RIS Market: PACS Segment to Capture Largest Market Share

Transparency Market Research has published a new report titled, PACS and RIS Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

December 1, 2020
·
5 min read
Oil-free Dental Vacuum Pumps Market: Rise in prevalence of periodontal diseases to drive the market

Dental vacuum pumps are devices used for the suction of residue or fluids resulting from dental surgeries.

December 1, 2020
·
5 min read